Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JJU
1751
DELISTED
iPath Series B Bloomberg Aluminum Subindex Total ReturnSM ETN
JJU
| $4.01M | ﹤0.01% |
80,000
| – | – |
|
1752
New York Times
NYT
$10.2B
| $4.01M | ﹤0.01% |
123,532
+33,645
| +37% | +$1.1M |
|
1753
New Jersey Resources
NJR
$5.58B
| $4M | ﹤0.01% |
80,581
+54,276
| +206% | +$2.48M |
|
1754
Par Pacific Holdings
PARR
$3.32B
| $4M | ﹤0.01% |
171,919
+157,844
| +1,121% | +$3.44M |
|
|
MNRL
1755
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $4M | ﹤0.01% |
122,945
+106,206
| +634% | +$3.42M |
|
1756
nVent Electric
NVT
$26.7B
| $3.97M | ﹤0.01% |
103,298
-5,401
| -5% | -$199K |
|
|
BLUE
1757
DELISTED
bluebird bio
BLUE
| $3.96M | ﹤0.01% |
28,579
-1,524
| -5% | -$215K |
|
1758
CALL
PVH
PVH
$4.04B
| $3.95M | ﹤0.01% |
+56,000
| New | +$3.34M |
|
1759
Brookfield Renewable
BEPC
$6.26B
| $3.95M | ﹤0.01% |
143,450
+24,762
| +21% | +$765K |
|
1760
Performance Food Group
PFGC
$18B
| $3.95M | ﹤0.01% |
67,645
-54,036
| -44% | -$2.94M |
|
1761
CALL
Accenture
ACN
$108B
| $3.95M | ﹤0.01% |
14,800
+9,400
| +174% | +$2.6M |
|
|
CIVI
1762
DELISTED
Civitas Resources
CIVI
| $3.94M | ﹤0.01% |
68,092
+9,443
| +16% | +$609K |
|
|
LNW
1763
DELISTED
Light & Wonder
LNW
| $3.93M | ﹤0.01% |
67,008
+36,235
| +118% | +$2.07M |
|
1764
Guardant Health
GH
$22.6B
| $3.93M | ﹤0.01% |
144,332
-33,317
| -19% | -$1.52M |
|
1765
Tandem Diabetes Care
TNDM
$1.56B
| $3.92M | ﹤0.01% |
87,258
-14,382
| -14% | -$651K |
|
|
VERV
1766
DELISTED
Verve Therapeutics
VERV
| $3.92M | ﹤0.01% |
202,389
+88,718
| +78% | +$2.35M |
|
1767
Broadstone Net Lease
BNL
$4.02B
| $3.91M | ﹤0.01% |
241,440
+74,590
| +45% | +$1.25M |
|
1768
Penske Automotive Group
PAG
$14.2B
| $3.91M | ﹤0.01% |
34,009
-15,500
| -31% | -$1.77M |
|
1769
Highwoods Properties
HIW
$3.47B
| $3.91M | ﹤0.01% |
139,653
+2,699
| +2% | +$75K |
|
1770
Editas Medicine
EDIT
$442M
| $3.91M | ﹤0.01% |
440,401
+140,174
| +47% | +$1.54M |
|
1771
CALL
Zoom
ZM
$30.6B
| $3.9M | ﹤0.01% |
+57,500
| New | +$4.37M |
|
1772
PUT
MGM Resorts International
MGM
$11.2B
| $3.89M | ﹤0.01% |
+116,100
| New | +$4.02M |
|
1773
Travere Therapeutics
TVTX
$5.78B
| $3.89M | ﹤0.01% |
184,786
+47,873
| +35% | +$1.01M |
|
1774
VanEck Oil Services ETF
OIH
$1.92B
| $3.87M | ﹤0.01% |
12,744
-39,070
| -75% | -$11.2M |
|
|
IMGN
1775
DELISTED
Immunogen Inc
IMGN
| $3.87M | ﹤0.01% |
780,649
+168,152
| +27% | +$912K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.